James M. Hindman has served on Accuray's Board since September 2019 and chairs the Audit Committee. He held various positions at Allergan from 1984 to 2015, most recently as Executive Vice President, Finance and Business Development, and Chief Financial Officer, and earlier as Senior Vice President of Treasury, Risk and Investor Relations. He currently serves on the board of Aatru Medical and has served on the boards of Millendo Therapeutics, Sienna Biopharmaceuticals, Urovant Sciences and Amolyt Pharma. He holds a B.S. in Accounting from Loyola Marymount University and an MBA from Pepperdine University, and is a California CPA (inactive).